- Home
- UHS vs DGX Comparison
UHS vs DGX Comparison
Compare UHS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHS
- DGX
- Stock Information
- Founded
- UHS 1978
- DGX 1967
- Country
- UHS United States
- DGX United States
- Employees
- UHS N/A
- DGX N/A
- Industry
- UHS Hospital/Nursing Management
- DGX Medical Specialities
- Sector
- UHS Health Care
- DGX Health Care
- Exchange
- UHS Nasdaq
- DGX Nasdaq
- Market Cap
- UHS 14.9B
- DGX 17.5B
- IPO Year
- UHS N/A
- DGX 1996
- Fundamental
- Price
- UHS $201.75
- DGX $160.46
- Analyst Decision
- UHS Buy
- DGX Buy
- Analyst Count
- UHS 17
- DGX 13
- Target Price
- UHS $227.31
- DGX $163.38
- AVG Volume (30 Days)
- UHS 831.1K
- DGX 1.0M
- Earning Date
- UHS 10-24-2024
- DGX 10-22-2024
- Dividend Yield
- UHS 0.40%
- DGX 1.87%
- EPS Growth
- UHS 57.82
- DGX 11.56
- EPS
- UHS 15.03
- DGX 7.44
- Revenue
- UHS $15,417,759,000.00
- DGX $9,539,000,000.00
- Revenue This Year
- UHS $11.17
- DGX $7.33
- Revenue Next Year
- UHS $6.34
- DGX $8.69
- P/E Ratio
- UHS $13.42
- DGX $21.57
- Revenue Growth
- UHS 9.93
- DGX 2.60
- 52 Week Low
- UHS $133.70
- DGX $123.04
- 52 Week High
- UHS $243.25
- DGX $162.59
- Technical
- Relative Strength Index (RSI)
- UHS 37.91
- DGX 60.76
- Support Level
- UHS $193.79
- DGX $156.10
- Resistance Level
- UHS $211.11
- DGX $162.59
- Average True Range (ATR)
- UHS 5.37
- DGX 2.91
- MACD
- UHS -0.39
- DGX 0.37
- Stochastic Oscillator
- UHS 43.31
- DGX 79.72
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.